GENETRON HOLDINGS LTD-ADR (GTH) Stock Price & Overview
NASDAQ:GTH • US37186H2094
Current stock price
The current stock price of GTH is 4.025 USD. Today GTH is up by 0.12%. In the past month the price increased by 2.68%. In the past year, price increased by 27.78%.
GTH Key Statistics
- Market Cap
- 127.288M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -3.54
- Dividend Yield
- N/A
GTH Stock Performance
GTH Stock Chart
GTH Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to GTH. When comparing the yearly performance of all stocks, GTH is one of the better performing stocks in the market, outperforming 76.99% of all stocks.
GTH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GTH. Both the profitability and financial health of GTH have multiple concerns.
GTH Earnings
GTH Forecast & Estimates
5 analysts have analysed GTH and the average price target is 1.39 USD. This implies a price decrease of -65.54% is expected in the next year compared to the current price of 4.025.
For the next year, analysts expect an EPS growth of 20.69% and a revenue growth 25.16% for GTH
GTH Groups
Sector & Classification
GTH Financial Highlights
Over the last trailing twelve months GTH reported a non-GAAP Earnings per Share(EPS) of -3.54. The EPS decreased by -61.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.89% | ||
| ROE | -148.03% | ||
| Debt/Equity | 0.05 |
GTH Ownership
GTH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GTH
Company Profile
Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.
Company Info
IPO: 2020-06-19
GENETRON HOLDINGS LTD-ADR
1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District
Beijing BEIJING 102206 CN
CEO: Sizhen Wang
Employees: 799
Phone: 861050907500
GENETRON HOLDINGS LTD-ADR / GTH FAQ
Can you describe the business of GENETRON HOLDINGS LTD-ADR?
Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.
What is the current price of GTH stock?
The current stock price of GTH is 4.025 USD. The price increased by 0.12% in the last trading session.
Does GENETRON HOLDINGS LTD-ADR pay dividends?
GTH does not pay a dividend.
What is the ChartMill technical and fundamental rating of GTH stock?
GTH has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for GTH stock?
5 analysts have analysed GTH and the average price target is 1.39 USD. This implies a price decrease of -65.54% is expected in the next year compared to the current price of 4.025.
Can you provide the PE ratio for GTH stock?
GENETRON HOLDINGS LTD-ADR (GTH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.54).